TABLE 3.
Subset of genes conserved between both microarray data sets
| Full gene name | Gene symbol | Functional relationship to treatment | Fold change (antagonist/agonist) |
|---|---|---|---|
| Serpin peptidase inhibitor, clade A, member 3 | SERPINA3 | Known downstream target of MR in cardiac cells (25) | −2.2 |
| FBJ murine osteosarcoma viral oncogene homolog | FOS | Up-regulated by aldosterone and GR-overexpression (25, 50) | −2.6 |
| Growth arrest and DNA-damage-inducible, β | GADD45B | Up-regulated in stressful growth conditions (52) | −2.2 |
| Ankyrin repeat domain 1 | ANKRD1 | Transcript levels altered in numerous muscle diseases (36) | −2.2 |
| Natriuretic peptide receptor C/guanylate cyclase C | NPR3 | Involved in MR-regulated pathways (46) | −2.5 |
These gene changes are likely caused directly by MR modulation; gene function or regulation related to treatment is listed.